Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms

Sep 16th, 2025 Chronic Inflammation and Obesity Discover how chronic inflammation fuels obesity from withinand learn actionable steps to break the cycle and reclaim your health
Protect From Light
American Family Physician, 96(6), 384-388
TB500 supports muscle and joint recovery while reducing inflammation, making it ideal for individuals looking to improve physical performance and recover from injuries more efficiently
Strictly no compromises